pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,571 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07619976: Effects of New Zealand Blackcurrant Supplementation on Exercise and Cognitive Performance in Resistance-Trained Adults

Sponsor: Jacksonville State University. Phase: NA. Conditions: Resistance Exercise Performance, Cognitive Function, Anaerobic Performance, Dietary Supplementation Athletic Performance

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07616076: Olfactory Communication in the First Days of Life: From Chemical Mechanisms to Improved Breastfeeding

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Mother Who Has Given Birth to a Singleton Newborn, Mother-newborn Dyad, Singleton Newborn

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07670117: HAIQU (Hospital AIr QUality)

Sponsor: Mayo Clinic. Phase: NA. Conditions: Acute Respiratory Tract Infection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04543617: A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Esophageal Squamous Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06732440: Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation

Sponsor: Creighton University. Phase: NA. Conditions: Vestibular Hypofunction, Bilateral Vestibular Hypofunction, Presbyvestibulopathy, Healthy Controls

full page →ctgov ↗
›RECRUITINGphase readoutNCT06535568: Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS. Phase: NA. Conditions: Coronary Disease, Heart Diseases, Cardiovascular Diseases, Myocardial Ischemia, Atherosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Coronary Artery Disease, Acute Coronary Syndrome, Coronary Stenosis, Molecular Mechanisms of Pharmacological Action, Enzyme Inhibitors, MTOR Inhibitors, Protein Kinase Inhibitors, Physiological Effects of Drugs, Immunosuppressive Agents, Antineoplastic Agents, High Bleeding Risk, Single Antiplatelet Therapy, Dual Antiplatelet Therapy, Cyclooxygenase Inhibitors, P2Y12 Inhibitor, Platelet Aggregation Inhibitors, Aspirin, Clopidogrel

full page →ctgov ↗
›RECRUITINGphase readoutNCT07224750: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Sponsor: City of Hope Medical Center. Phase: . Conditions: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer (GC), Colorectal Cancer Screening

full page →ctgov ↗
›RECRUITINGphase readoutNCT00162474: Determinants of Warfarin Metabolism

Sponsor: Hadassah Medical Organization. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05498974: China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Sponsor: Second Xiangya Hospital of Central South University. Phase: . Conditions: Type1diabetes, Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07428018: Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib

Sponsor: Mario Negri Institute for Pharmacological Research. Phase: PHASE2. Conditions: Breast Cancer, HER2 + Breast Cancer, HR Positive, Neoadjuvant Therapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07579390: Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)

Sponsor: Helsinki University Central Hospital. Phase: NA. Conditions: Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU, Sedation in Intensive Care, Blood Pressure, Mean Arterial Pressure Targets, Temperature, Fever, Resuscitated Sudden Cardiac Death, Out of Hospital Cardiac Arrest, Cardiac Arrest (CA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07607197: Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Sponsor: Hospital Universitari Vall d'Hebron Research Institute. Phase: PHASE1. Conditions: Kidney Failure, Chronic, Kidney Transplantation, Alloimmunization, HLA Sensitization, End Stage Cronic Kidney Disease, Highly Sensitized Patients Awaiting Kidney Transplant

full page →ctgov ↗
›RECRUITINGphase readoutNCT07222410: Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Sponsor: Fisher and Paykel Healthcare. Phase: NA. Conditions: COPD

full page →ctgov ↗
›RECRUITINGphase readoutNCT07052513: Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery

Sponsor: M2RLAB SL. Phase: PHASE2. Conditions: Acute Kidney Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07330713: Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

Sponsor: Uludag University. Phase: NA. Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02462460: Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Screening Breast MRI in Patients Who Are BRCA Mutation Carriers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07585760: CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Multiple Myeloma (MM), Multiple Myeloma Light Chain Induced Renal Insufficiency

full page →ctgov ↗
›COMPLETEDphase readoutNCT07729020: Effectiveness of Virtual Reality in Reducing Anxiety and Pain During the First Postoperative Orthopedic Dressing Change in Pediatric Patients

Sponsor: Gianluca Catania. Phase: NA. Conditions: Anxiety, Pain, Post Operative

full page →ctgov ↗
›COMPLETEDphase readoutNCT07471620: The Effect of High Intensity Functional Exercise Programs on Menopausal Symptoms, Physical Performance, and Dual Task Performance in Postmenopausal Women

Sponsor: Uskudar University. Phase: NA. Conditions: Postmenopausal Period

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07528820: Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps

Sponsor: St. Paul's Sinus Centre. Phase: NA. Conditions: CRSwNP, Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04142320: Closed-loop Optimized rTMS for Depression

Sponsor: Stanford University. Phase: PHASE1. Conditions: Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372820: METABolic Deterioration in HTX Determines Outcomes

Sponsor: Heinrich-Heine University, Duesseldorf. Phase: . Conditions: Heart Transplantation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07362524: AI-Assisted Real-Time Endoscopic Characterization of Diminutive Colorectal Polyps in Non-Academic Hospitals

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Colorectal Polyps

full page →ctgov ↗
›RECRUITINGphase readoutNCT06912724: Pediatric Neuroimaging

Sponsor: National Institute on Aging (NIA). Phase: . Conditions: Neurogimaging

full page →ctgov ↗
›COMPLETEDphase readoutNCT05987696: Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: AML, Adult, Minimal Residual Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04301596: Assessment of Nutritional Status in Systemic Sclerosis

Sponsor: University Hospital, Montpellier. Phase: . Conditions: Systemic Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06840496: To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Sponsor: Biomed Industries, Inc.. Phase: PHASE3. Conditions: Rett Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07228962: Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

Sponsor: King's College London. Phase: . Conditions: Eczema, Atopic Dermatitis, Atopic Eczema

full page →ctgov ↗
›COMPLETEDphase readoutNCT06545162: Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Overweight and Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06639503: Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Tibial Plateau Fractures

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06384261: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

Sponsor: OncoVerity, Inc.. Phase: PHASE2. Conditions: Leukemia, Myeloid, Acute

full page →ctgov ↗
›COMPLETEDphase readoutNCT05497427: Normative Database and Test-Retest Reliability for BrainCheck Assessments

Sponsor: BrainCheck, Inc.. Phase: . Conditions: Cognitive Change, Cognitive Decline, Cognitive Deterioration, Neurocognitive Deficit

full page →ctgov ↗
›RECRUITINGphase readoutNCT06687070: APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Sponsor: Ascentage Pharma Group Inc.. Phase: PHASE1. Conditions: Platinum-resistant Recurrent Ovarian Cancer, Advanced Solid Tumor

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04789070: Phase III Trial of Sirolimus in IBM

Sponsor: University of Kansas Medical Center. Phase: PHASE3. Conditions: Inclusion Body Myositis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04302870: Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Sponsor: University of Edinburgh. Phase: PHASE2. Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05796570: A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Sponsor: Franziska Wachter. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloid Malignancies, MDS, Inherited Bone Marrow Failure Syndrome, Myeloid Neoplasm, Aml

full page →ctgov ↗
›TERMINATEDphase readoutNCT04869670: A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

Sponsor: Mayo Clinic. Phase: NA. Conditions: Gastroparesis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05756270: Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

Sponsor: University of Milano Bicocca. Phase: . Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07445373: Role of the WHO Labour Care Guide in Improving Maternal and Fetal Outcomes

Sponsor: Khyber Teaching Hospital. Phase: NA. Conditions: Labor and Delivery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06651073: ATTR-CM: A Multi-country, Non-interventional Disease Registry

Sponsor: Pfizer. Phase: . Conditions: Transthyretin Amyloid Cardiopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06870669: The Effect of Progressive Relaxation Exercises by Nursing Students Before Clinical Practice

Sponsor: Manisa Celal Bayar University. Phase: NA. Conditions: Healthy, Stress, Exercise

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07663773: Thyroid Hormones in CKD

Sponsor: Mario Negri Institute for Pharmacological Research. Phase: . Conditions: Chronic Kidney Disease (Stages 4 and 5)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07233655: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Moderate to Severe Active Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07243626: Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Soft Tissue Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07430826: Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa

Sponsor: University of Washington. Phase: NA. Conditions: Neurodevelopment, Child Growth

full page →ctgov ↗
›RECRUITINGphase readoutNCT03448926: The PREDICT Registry:

Sponsor: PreludeDx. Phase: . Conditions: DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ

full page →ctgov ↗
›RECRUITINGphase readoutNCT07224178: Left Atrial Strain and Cryptogenic Stroke

Sponsor: University of Pittsburgh. Phase: . Conditions: Ischemic Stroke, Cryptogenic, Ischemic Stroke, Embolic, Hemorrhagic Stroke, Embolic Stroke of Undetermined Source, Recurrent Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07489378: NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Very Rare Tumors, Very Rare Cancers, Other Solid Tumors, Solid Tumor, Pediatric Rare Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT03123978: Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07586748: Pressure Ulcer Development Device Related

Sponsor: Assuta Medical Center. Phase: . Conditions: Pressure Ulcer, Pressure Ulcer Prevention, Venous Thrombosis Deep (Limbs)

full page →ctgov ↗
← prev
page 105 of 112
next →